Harbin Gloria Pharmaceuticals Co., Ltd. (002437.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 3.44

From 52W high−20.88%

Volume290.76M

Market capCNY 8.79B

P/E (TTM)23.3x

P/S (TTM)3.6x

Div yield—

Key dataSep 18, 2026

Open

CNY 3.44

From 52W high

−20.88%

Volume

290.76M

Market cap

CNY 8.79B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

14.4x

P/E (TTM)

23.3x

RSI (14)

43.3

MomentumView details →

1D Return

−9.43%

YTD Return

+13.03%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

23.3x

EV/EBITDA

14.4x

EV/Sales

3.3x

P/S (TTM)

3.6x

P/B (TTM)

3.7x

ProfitabilityView details →

Gross Margin

44.48%

Net Margin

19.38%

EBITDA Margin

23.28%

ROE (TTM)

17.24%

ROA (TTM)

13.10%

Asset Turnover

0.68x

GrowthView details →

Revenue YoY

−11.49%

EPS YoY

+72.52%

FCF YoY

−27.78%

Revenue CAGR 3Y

−11.76%

EPS CAGR 3Y

+77.27%

EBITDA YoY

—

MomentumView details →

1D Return

−9.43%

YTD Return

+13.03%

1Y Return

+3.27%

RSI (14)

43.3

vs 50D SMA

−3.73%

vs 200D SMA

+4.40%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

1.90x

Quick Ratio

1.61x

Div Yield

—

Div Rate

—

Div Growth 1Y

−20.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.12B

Net Income (TTM)

411.58M

Op. CF (TTM)

239.59M

Latest newsMore news →

Certain directors and senior executives of Yuheng Pharmaceutical plan to collectively reduce their holdings by no more than 11.5709 million shares, or 0.5189% of total share capital, via centralized bidding.6d ago

Yuhuan Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 159 million yuan, up 18.27% year-on-year, with revenue of 1.007 billion yuan, down 8.41%.25d ago

Similar companies

力合科创002243.SZ 漫步者002351.SZ 中利集团002309.SZ 水羊股份300740.SZ 慧翰股份301600.SZ 青鸟智控002960.SZ Find similar companies →

Latest newsMore news →

Certain directors and senior executives of Yuheng Pharmaceutical plan to collectively reduce their holdings by no more than 11.5709 million shares, or 0.5189% of total share capital, via centralized bidding.6d ago Yuhuan Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 159 million yuan, up 18.27% year-on-year, with revenue of 1.007 billion yuan, down 8.41%.25d ago